We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cross-transmission Is Not the Source of New Mycobacterium abscessus Infections in a Multicenter Cohort of Cystic Fibrosis Patients.
- Authors
Doyle, Ronan M; Rubio, Marc; Dixon, Garth; Hartley, John; Klein, Nigel; Coll, Pere; Harris, Kathryn A
- Abstract
Background Mycobacterium abscessus is an extensively drug–resistant pathogen that causes pulmonary disease, particularly in cystic fibrosis (CF) patients. Identifying direct patient-to-patient transmission of M. abscessus is critically important in directing an infection control policy for the management of risk in CF patients. A variety of clinical labs have used molecular epidemiology to investigate transmission. However, there is still conflicting evidence as to how M. abscessus is acquired and whether cross-transmission occurs. Recently, labs have applied whole-genome sequencing (WGS) to investigate this further and, in this study, we investigated whether WGS can reliably identify cross-transmission in M. abscessus. Methods We retrospectively sequenced the whole genomes of 145 M. abscessus isolates from 62 patients, seen at 4 hospitals in 2 countries over 16 years. Results We have shown that a comparison of a fixed number of core single nucleotide variants alone cannot be used to infer cross-transmission in M. abscessus but does provide enough information to replace multiple existing molecular assays. We detected 1 episode of possible direct patient-to-patient transmission in a sibling pair. We found that patients acquired unique M. abscessus strains even after spending considerable time on the same wards with other M. abscessus– positive patients. Conclusions This novel analysis has demonstrated that the majority of patients in this study have not acquired M. abscessus through direct patient-to-patient transmission or a common reservoir. Tracking transmission using WGS will only realize its full potential with proper environmental screening, as well as patient sampling.
- Subjects
CYSTIC fibrosis treatment; MYCOBACTERIAL disease diagnosis; PREVENTION of communicable diseases; INFECTIOUS disease transmission; CROSS infection; GENOMES; LONGITUDINAL method; MEDICAL cooperation; MOLECULAR epidemiology; MYCOBACTERIUM; NUCLEOTIDES; RESEARCH; RISK management in business; COMMUNITY-acquired infections; RETROSPECTIVE studies; SEQUENCE analysis
- Publication
Clinical Infectious Diseases, 2020, Vol 70, Issue 9, p1855
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciz526